Price hike for Pfizer and Moderna coronavirus vaccines in Europe

Brussels has always refused to reveal the price it pays for the vaccines.
Brussels has always refused to reveal the price it pays for the vaccines. / SUR
  • The details of the new agreements were revealed by the UK's Financial Times newspaper

The pharmaceutical companies Pfizer and Moderna have increased the prices of their Covid-19 vaccines through a new agreement with the European Union, according the UK’s Financial Times, which has seen the contract.

The price of Pfizer's vaccine increased from 15.50 euros ($18.39) to 19.50 euros ($23.14) per unit and Moderna's, from 19 euros ($22.50) to 21.50 euros ($25.50), according to the British financial newspaper.

This increase comes at a time when the delta variant is more prominent, which the vaccines of the American companies Pfizer and Moderna should be more effective in preventing severe forms of the coronavirus, according to the first studies.

Contacted by the AFP news agency, the European Commission declined to comment. The pharmaceutical companies did not respond either.

Brussels has always refused to reveal the price of its orders for the vaccines, although in December a Belgian minister revealed it on Twitter, before quickly deleting it.

In May, the EU agreed a new contract with Pfizer / BioNTech to purchase 1.8 billion doses of its Covid-19 vaccine through 2023, although it did not indicate the price.

The President of the European Commission, Ursula von der Leyen, announced in July that they had achieved their goal of having enough doses to vaccinate 70 per cent of adult Europeans (336 million people).

The European countries' joint vaccine purchase programme ordered some 330 million doses of the vaccine from Pfizer, 100 million from AstraZeneca, 50 million from Moderna and 20 million from Johnson & Johnson.